TP53 and neoplasm: Moreover, the therapeutic efficacy of inducible anti‐tumor proteins (PNFAT‐p53+PNF6‐DAPK3) was comparable to that of the constitutive group (PCMV‐p53), indicating that the timing of LVs injection did not affect the therapeutic efficacy (Figure S11, Supporting Information).